EULAR and ACR COVID19 Guidelines: Similarities Provide Reassurance

Save

In difficult times, it's reassuring to reflect on the similarities that bring us together. In the case of the EULAR and ACR COVID19 guidelines as discussed at #EULAR2020 by Drs.

Hydroxychloroquine Postexposure Prophylaxis for COVID-19 Fails

Save

NEJM has reported that the use of hydroxychloroquine did not prevent symptomatic COVID-19 infection when used within 4 days after SARS-CoV-2 exposure.

Currently for persons who are COVID exposed, the standard of care is quarantine and there is no known preventative therapy.

TNR Grand Rounds - Update on Biosimilars

Save

This week's Tuesday Nite Rheumatology featured Dr Jonathan Kay (U Mass) who gave an update on Biosimilars and took questions the subject. The program was moderated by Dr. Jack Cush.

Noninflammatory Pain Persists in RA Despite Treatment

Save

Almost one-third of patients with new-onset rheumatoid arthritis (RA) reported persistent unacceptable pain after 21 months of combination therapy, according to a study by Swedish researchers.A total of 29% of patients continued to have unacceptable pain.

First Look at COVID-19 Global Rheumatology Alliance Registry

Save

Gianfresco et al have published the first peer-reviewed analysis of COVID-19 infected, rheumatic disease patients entered into the Rheumatology Global Alliance registry; showing that a) rheumatic disease patient can be infected with COVID-19, b) that DMARD and biologic use has no apparent effect on outcomes and c) steroid increase and TNF inhibitor decrease the odds of hospitalization.

RheumNow Podcast - Rheumatic Patients with COVID (5.29.20)

Save

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Targeting the Wnt Pathway Fails in OA

Save

The Wnt pathway modulator lorecivivint failed to meet the primary endpoint in a phase IIa study for knee osteoarthritis (OA), but showed promise in certain patient subgroups, researchers reported.